These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15526004)

  • 61. Genetic variability in the severity and outcome of community-acquired pneumonia.
    Solé-Violán J; de Castro Fv; García-Laorden MI; Blanquer J; Aspa J; Borderías L; Briones ML; Rajas O; Carrondo IM; Marcos-Ramos JA; Ferrer Agüero JM; Garcia-Saavedra A; Fiuza MD; Caballero-Hidalgo A; Rodriguez-Gallego C
    Respir Med; 2010 Mar; 104(3):440-7. PubMed ID: 19900796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases.
    Ozturk C; Aksu G; Berdeli A; Kutukculer N
    Clin Exp Med; 2006 Mar; 6(1):27-32. PubMed ID: 16550341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Understanding the Genomic Structure of Copy-Number Variation of the Low-Affinity Fcγ Receptor Region Allows Confirmation of the Association of FCGR3B Deletion with Rheumatoid Arthritis.
    Rahbari R; Zuccherato LW; Tischler G; Chihota B; Ozturk H; Saleem S; Tarazona-Santos E; Machado LR; Hollox EJ
    Hum Mutat; 2017 Apr; 38(4):390-399. PubMed ID: 27995740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
    Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients.
    Azevedo ZM; Moore DB; Lima FC; Cardoso CC; Bougleux R; Matos GI; Luz RA; Xavier-Elsas P; Sampaio EP; Gaspar-Elsas MI; Moraes MO
    Hum Immunol; 2012 Jun; 73(6):661-7. PubMed ID: 22507624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.
    Meletiadis J; Walsh TJ; Choi EH; Pappas PG; Ennis D; Douglas J; Pankey GA; Larsen RA; Hamill RJ; Chanock S
    Med Mycol; 2007 Sep; 45(6):513-8. PubMed ID: 17710620
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients.
    Hu XP; Wu JQ; Zhu LP; Wang X; Xu B; Wang RY; Ou XT; Weng XH
    PLoS One; 2012; 7(8):e42439. PubMed ID: 22879986
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study.
    Foster CB; Zhu S; Erichsen HC; Lehrnbecher T; Hart ES; Choi E; Stein S; Smith MW; Steinberg SM; Imbach P; Kühne T; Chanock SJ;
    Br J Haematol; 2001 Jun; 113(3):596-9. PubMed ID: 11380443
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular determinants of disease severity in urinary tract infection.
    Ambite I; Butler D; Wan MLY; Rosenblad T; Tran TH; Chao SM; Svanborg C
    Nat Rev Urol; 2021 Aug; 18(8):468-486. PubMed ID: 34131331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.
    McIlwrath SL; Nesemeier R; Ma F; Oz HS; Zhang L; Westlund KN
    Eur J Pain; 2017 Aug; 21(7):1209-1223. PubMed ID: 28318085
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Genetics of Urinary Tract Infections and the Innate Defense of the Kidney and Urinary tract.
    Ambite I; Rydstrom G; Schwaderer AL; Hains DS
    J Pediatr Genet; 2016 Mar; 5(1):25-32. PubMed ID: 27617139
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rheumatoid Arthritis: The Stride from Research to Clinical Practice.
    Chung IM; Ketharnathan S; Thiruvengadam M; Rajakumar G
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338350
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis.
    Zhang C; Wang W; Zhang H; Wei L; Guo S
    Oncotarget; 2016 Jun; 7(26):39436-39443. PubMed ID: 27270653
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The innate immune response during urinary tract infection and pyelonephritis.
    Spencer JD; Schwaderer AL; Becknell B; Watson J; Hains DS
    Pediatr Nephrol; 2014 Jul; 29(7):1139-49. PubMed ID: 23732397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections.
    Ragnarsdóttir B; Svanborg C
    Pediatr Nephrol; 2012 Nov; 27(11):2017-2029. PubMed ID: 22327887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis.
    Graf SW; Lester S; Nossent JC; Hill CL; Proudman SM; Lee A; Rischmueller M
    Arthritis Res Ther; 2012 Feb; 14(1):R28. PubMed ID: 22309893
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetics of innate immunity and UTI susceptibility.
    Ragnarsdóttir B; Lutay N; Grönberg-Hernandez J; Köves B; Svanborg C
    Nat Rev Urol; 2011 Jul; 8(8):449-68. PubMed ID: 21750501
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.
    Okuyama A; Nagasawa H; Suzuki K; Kameda H; Kondo H; Amano K; Takeuchi T
    Ann Rheum Dis; 2011 Feb; 70(2):299-304. PubMed ID: 20980704
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Japanese experience with biologic therapies for rheumatoid arthritis.
    Takeuchi T; Kameda H
    Nat Rev Rheumatol; 2010 Nov; 6(11):644-52. PubMed ID: 20877307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus.
    Kinder BW; Freemer MM; King TE; Lum RF; Nititham J; Taylor K; Edberg JC; Bridges SL; Criswell LA
    Arthritis Rheum; 2007 Aug; 56(8):2679-86. PubMed ID: 17665457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.